ST. JOSEPH, Mich., April 24 /PRNewswire/ -- GeneGo, Inc., a leading provider of software and databases for systems biology and XB TransMed Solutions, a translation medicine software and services company, today announced that their flagship products, MetaCore and XB-BioIntegration Suite (XB-BIS) are fully integrated. Mutual customers can capture, manage and mine integrated clinical, preclinical and molecular data in its various forms and statistically analyze data associations using XB-BIS, and functionally analyze the associated results in the context of biological pathways, networks, cellular processes and disease networks in MetaCore.
“XB-BIS has been developed to fulfill the need in translational medicine for efficient data capture, management, analysis and reporting in an intuitive workflow that resembles the natural translational path from early hypothesis generation to validation and application in the areas of clinical diagnostics and intervention,” said Dr. Craig Webb, Program Director for Translational Medicine at the Van Andel Institute. “Integration with the MetaCore systems biology toolsets permits the user to seamlessly integrate back and forth between expanding knowledge and enhanced application.”
“Over the past year, we have seen an increasing demand in systems biology solutions from the clinical trial market,” said Julie Bryant, Vice President of Business Development at GeneGo. “Understanding the differences of drug effects on individual patients is a very challenging task, which requires state of the art tools in both translational medicine and functional data mining. We are very pleased to join forces with XenoBase inventors Dr. Craig Webb and Dr. Jeremy Miller at the Van Andel Institute to develop analytical workflows for the clinical environment.”
About GeneGo
GeneGo develops systems biology technology for life science research. The original computational platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, siRNA and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo’s flagship product, MetaCore 3.0, assists pharmaceutical scientists in the areas of target selection and validation, identification of biomarkers for disease states and toxicology. The second product, MetaDrug(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore. For more information, please visit the company’s web site at www.genego.com.
MetaCore(TM), MetaBase(TM) and MetaDrug(TM) are trademarks of GeneGo, Inc.
About XB TransMed Solutions
XB TransMed Solutions, was founded as a next generation life science application and services company with headquarters in Grand Rapids, Michigan. The focus of XB TransMed Solutions is to provide leading edge software and service solutions expediting the complete life science work process from novel discovery to clinical application in an integrated environment. XB Trans Med markets its Bio-Integration Suite as a fully integrated biological and medical informatics solution that allows users to generate, refine, and validate causal hypotheses across disparate data sets. The purpose is to provide a complete solution in the area of translational biomedical research, whereby bench-side research can rapidly lead to discoveries that can be readily applied to bedside medicine.
XB Bio-Integration Suite are trademarks of XB TransMed Solutions, LLC
GeneGo, Inc.
CONTACT: Julie Bryant, VP Business Development and Marketing of GeneGo,Inc., +1-858-756-7996, julie@genego.com
Web site: http://www.genego.com/
